alpha tocopherol transfer protein
Dernière mise à jour 4 mai 2023
Respecte les directives éditoriales
- TéléchargerTélécharger
- Partager
- Language
- Discussion
- Ask Patient
- Version audio
- Ajouter aux sources préférées sur Google
The TTPA gene provides instructions for making the α-tocopherol transfer protein (αTTP), which is found in the liver and brain. This protein controls the distribution of vitamin E obtained from the diet (also called α-tocopherol) to cells and tissues throughout the body. Vitamin E is an antioxidant that protects cells in the body from the damaging effects of unstable molecules called free radicals. Normally, vitamin E derived from food is absorbed in the intestine and then transported into the liver on molecules called chylomicrons.
Sélections vidéo pour GènesBibliothèque vidéo
Normal function
The TTPA gene provides instructions for making the α-tocopherol transfer protein (αTTP), which is found in the liver and brain. This protein controls the distribution of vitamin E obtained from the diet (also called α-tocopherol) to cells and tissues throughout the body. Vitamin E is an antioxidant that protects cells in the body from the damaging effects of unstable molecules called free radicals. Normally, vitamin E derived from food is absorbed in the intestine and then transported into the liver on molecules called chylomicrons.
After a meal, chylomicrons are formed to transport fat-soluble vitamins (such as vitamin E), dietary fats, and cholesterol from the intestine to the liver. Once in the liver, αTTP transfers vitamin E from chylomicrons to very low-density lipoproteins (VLDLs), which carry fat, fat-soluble vitamins, and cholesterol from the liver to other tissues throughout the body. The VLDLs are then released into the bloodstream so the accompanying vitamin E can be used in the body. The αTTP protein is also thought to transport vitamin E to nerve cells (neurons) in the brain.
Conditions referring to this gene or chromosome
Other names
alpha-tocopherol transfer protein
alphaTTP
ataxia (Friedreich-like) with vitamin E deficiency
ATTP
AVED
tocopherol (alpha) transfer protein
TTP1
TTPA_HUMAN
Related patient information and medicines

Patient information leaflet
Cancer primitif du foie
The behaviour, treatment and... The rest of this leaflet is only about primary liver cancer. Liver cancer symptoms There may be no symptoms in the early stage of the disease. This happens using ultrasound scans. Sometimes a blood test Blood tests for l'alpha-fœtoprotéine (AFP) is also taken at 6- to 12-monthly intervals although this is not a very.

Patient information leaflet
Tests de fonction hépatique
Tests de fonction hépatique are a set of sang tests commonly done to check on the health of your liver. Changes in liver function tests give a clue as to whether your liver is under strain, inflamed, infected or diseased, and how badly. Liver fonction Liver fonction La foie is a factory for the production and breakdown of carbohydrates, fats,.

Patient information leaflet
Mucolytiques
Mannitol is an alternative for people with cystic fibrosis who can't take dornas... How à prendre mucolytics Mucolytics work best when they are taken regularly. Carbocisteine and erdosteine are usually taken twice a day (but up to four times a day) by adults. Children may need to take these medicines three or four times a day. Dornase alfa is taken.

Patient information leaflet
Spondylarthrite ankylosante
Spondylarthrite ankylosante est an auto-immune disease. It is not known exactly why ankylosing spondylitis occurs but there is a genetic predisposition. 6 out of 100 people who have a particula... They are designed to target specific molecules of the immune system involved in inflammation. In ankylosing spondylitis, a chemical called cytokine tumour.

Patient information leaflet
Lentilles de contact
They are most commonly worn comme an alternative to spectacles to correct problems with your vision. They need to be looked after carefully. They don't mist up in the heat, you don't waste time trying to remember where you put them, they don't catch on your eyelashes when you blink, or make your eyes look bigger or smaller, and they don't get in the.

Patient information leaflet
Arthrite psoriasique
Some DMARDs also have a beneficial effect on r... Newer disease-modifying medicines A new class of recently developed medicines modify the effect of TNF alpha. The chemical TNF alpha plays an important role in causing inflammation in joints and skin. Blocking the effect of TNF alpha has been shown to reduce damage to joints and to reduce symptoms..
Lectures complémentaires et références
- alpha tocopherol transfer protein; MedlinePlus, National Library of Medicine.
- Mariotti C, Gellera C, Rimoldi M, Mineri R, Uziel G, Zorzi G, Pareyson D, Piccolo G, Gambi D, Piacentini S, Squitieri F, Capra R, Castellotti B, Di Donato S. Ataxia with isolated vitamin E deficiency: neurological phenotype, clinical follow-up and novel mutations in TTPA gene in Italian families. Neurol Sci. 2004 Jul;25(3):130-7. doi: 10.1007/s10072-004-0246-z.
- Meier R, Tomizaki T, Schulze-Briese C, Baumann U, Stocker A. The molecular basis of vitamin E retention: structure of human alpha-tocopherol transfer protein. J Mol Biol. 2003 Aug 15;331(3):725-34. doi: 10.1016/s0022-2836(03)00724-1.
- Morley S, Panagabko C, Shineman D, Mani B, Stocker A, Atkinson J, Manor D. Molecular determinants of heritable vitamin E deficiency. Biochemistry. 2004 Apr 13;43(14):4143-9. doi: 10.1021/bi0363073.
- Pang J, Kiyosawa M, Seko Y, Yokota T, Harino S, Suzuki J. Clinicopathological report of retinitis pigmentosa with vitamin E deficiency caused by mutation of the alpha-tocopherol transfer protein gene. Jpn J Ophthalmol. 2001 Nov-Dec;45(6):672-6. doi: 10.1016/s0021-5155(01)00425-7.
- Qian J, Atkinson J, Manor D. Biochemical consequences of heritable mutations in the alpha-tocopherol transfer protein. Biochemistry. 2006 Jul 11;45(27):8236-42. doi: 10.1021/bi060522c.
- Yokota T, Shiojiri T, Gotoda T, Arita M, Arai H, Ohga T, Kanda T, Suzuki J, Imai T, Matsumoto H, Harino S, Kiyosawa M, Mizusawa H, Inoue K. Friedreich-like ataxia with retinitis pigmentosa caused by the His101Gln mutation of the alpha-tocopherol transfer protein gene. Ann Neurol. 1997 Jun;41(6):826-32. doi: 10.1002/ana.410410621.
Partagez vos pensées ou expériences avec les autres dans notre communautés de patients.
Inscrivez-vous à la newsletter Patient
Votre dose hebdomadaire de conseils de santé clairs et fiables - rédigés pour vous aider à vous sentir informé, confiant et maître de la situation.
En vous abonnant, vous acceptez notre Politique de confidentialité. Vous pouvez vous désabonner à tout moment. Nous ne vendons jamais vos données.

